Skip to main content

Table 3 Adverse events occurred in three treatment group

From: Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

 

Tianzhi (n = 232)

Donepezil (n = 233)

Placebo (n = 55)

n (%)

n (%)

n (%)

Total

4 (1.72)

3 (1.29)

1 (1.82)

Diarrhea

0

1

0

Urinary tract Infection

2

0

0

Insomnia

0

0

1

Abnormal renal function

1

0

0

Arrhythmia

0

1

0

Loss of appetite

0

1

0

Bloating

1

0

0